Copyright
©The Author(s) 2016.
World J Gastroenterol. Aug 21, 2016; 22(31): 7069-7079
Published online Aug 21, 2016. doi: 10.3748/wjg.v22.i31.7069
Published online Aug 21, 2016. doi: 10.3748/wjg.v22.i31.7069
Table 1 Current status of selected endoscopic bariatric therapies
Device | Procedure | Mechanism | Regulatory status |
Orbera | Intragastric balloon | Space-occupying device | FDA-approved |
Integrated dual balloon | Intragastric balloon | Space-occupying device | FDA-approved |
OverStitch | Endoscopic sleeve gastroplasty | Gastric remodeling | FDA-approved1 |
Incisionless operating platform | Primary obesity surgery endolumenal | Gastric remodeling | Under FDA review |
Articulating circular endoscopic stapler | Gastroplasty | Gastric remodeling | In human trials |
AspireAssist | Aspiration therapy | Aspiration | FDA-approved |
Self-assembling magnets | Endoscopic enteral anastomosis | Dual-path enteral bypass | In human trials |
OverStitch | Transoral outlet reduction for revision of gastric bypass | Anastomotic reduction | FDA-approved1 |
Incisionless operating platform | Revision obesity surgery endolumenal for revision of gastric bypass | Anastomotic and pouch reduction | FDA-approved1 |
- Citation: Kumar N. Weight loss endoscopy: Development, applications, and current status. World J Gastroenterol 2016; 22(31): 7069-7079
- URL: https://www.wjgnet.com/1007-9327/full/v22/i31/7069.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i31.7069